These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11760727)

  • 1. Treatment of ankylosing spondylitis with infliximab.
    Boeger CA; Wittwer H; Schattenkirchner M; Kellner H; Kellner W
    Ann Rheum Dis; 2001 Dec; 60(12):1159-60. PubMed ID: 11760727
    [No Abstract]   [Full Text] [Related]  

  • 2. [New results from studies of therapy of ankylosing spondylitis with infliximab].
    Braun J
    Z Rheumatol; 2003 Apr; 62(2):108-9. PubMed ID: 12820612
    [No Abstract]   [Full Text] [Related]  

  • 3. Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation.
    de Vries MK; Wolbink GJ; Stapel SO; de Groot ER; Dijkmans BA; Aarden LA; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2007 Jan; 66(1):133-4. PubMed ID: 17178760
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to 'Evidence in Support of the Validity of the TNF Brake Hypothesis' by Maksymowych.
    Baraliakos X; Braun J
    Ann Rheum Dis; 2013 Dec; 72(12):e32-3. PubMed ID: 24058016
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of generalized tuberculosis in the use of infliximab (Remicade) in patients with Bekhterev's disease].
    Nekrasov EV; Strelis AK; Ianova GV; Filiniuk OV; Buĭnova LN
    Tuberk Biolezni Legkih; 2009; (8):56-60. PubMed ID: 19803353
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis.
    Capkin E; Karkucak M; Yayli S; Aydin Çapkin A; Tosun M
    J Clin Rheumatol; 2011 Aug; 17(5):293-4. PubMed ID: 21808187
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab: in ankylosing spondylitis.
    Robinson DM; Keating GM
    Drugs; 2005; 65(9):1283-91; discussion 1292-4. PubMed ID: 15916451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation.
    de Vries MK; Wolbink GJ; Stapel SO; de Vrieze H; van Denderen JC; Dijkmans BA; Aarden LA; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2007 Sep; 66(9):1252-4. PubMed ID: 17472991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological basis for the use of TNFalpha-blocking agents in ankylosing spondylitis and immunological changes during treatment.
    Zou JX; Braun J; Sieper J
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S34-7. PubMed ID: 12463444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of infliximab (Remicade) in the treatment of spondyloarthropathies. two case reports.
    Kaiser MJ; Sany J
    Joint Bone Spine; 2001 Dec; 68(6):525-7. PubMed ID: 11808993
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
    Braun J; Baraliakos X; Listing J; Fritz C; Alten R; Burmester G; Krause A; Schewe S; Schneider M; Sörensen H; Zeidler H; Sieper J
    Ann Rheum Dis; 2008 Mar; 67(3):340-5. PubMed ID: 17967831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study.
    Cantini F; Niccoli L; Benucci M; Chindamo D; Nannini C; Olivieri I; Padula A; Salvarani C
    Arthritis Rheum; 2006 Oct; 55(5):812-6. PubMed ID: 17013842
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines.
    Kassimos DG; Garyfallos A; Delamere J; Whallett A; Kitas GD
    Rheumatology (Oxford); 2003 Mar; 42(3):490. PubMed ID: 12626807
    [No Abstract]   [Full Text] [Related]  

  • 14. Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?
    Gaspersic N; Sersa I; Jevtic V; Tomsic M; Praprotnik S
    Ann Rheum Dis; 2008 Sep; 67(9):1354. PubMed ID: 18697784
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumour necrosis factor-α therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients.
    Genre F; Miranda-Filloy JA; López-Mejias R; Carnero-López B; Ochoa R; Rueda J; González-Juanatey C; Blanco R; Llorca J; González-Gay MA
    Ann Rheum Dis; 2013 Jul; 72(7):1265-7. PubMed ID: 23482472
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.
    Baraliakos X; Listing J; Rudwaleit M; Brandt J; Sieper J; Braun J
    Ann Rheum Dis; 2005 Oct; 64(10):1462-6. PubMed ID: 15778240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNFalpha: a new dimension in the pharmacotherapy of the spondyloarthropathies !?
    Braun J; Sieper J
    Ann Rheum Dis; 2000 Jun; 59(6):404-7. PubMed ID: 10834852
    [No Abstract]   [Full Text] [Related]  

  • 18. IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy.
    Jacquet A; Francois H; Frangie C; Yahiaoui Y; Ferlicot S; Micelli C; Mariette X; Durrbach A
    Nephrol Dial Transplant; 2009 Nov; 24(11):3540-2. PubMed ID: 19556300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.
    Baraliakos X; Listing J; Brandt J; Haibel H; Rudwaleit M; Sieper J; Braun J
    Rheumatology (Oxford); 2007 Sep; 46(9):1450-3. PubMed ID: 17623745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of antitumor necrosis factor(α) agents on patients with ankylosing spondylitis.
    Ren L; Li J; Luo R; Tang R; Zhu S; Wan L
    Am J Med Sci; 2013 Dec; 346(6):455-61. PubMed ID: 23715113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.